Related Experiment Video
Updated: Mar 18, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Physician Perspectives on the Transition to Primary Human Papillomavirus Testing for Cervical Cancer Screening
Peter W Ketch1, Teresa K L Boitano1, Norma A Longinos2
1Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The University of Alabama at Birmingham, Birmingham, AL.
Objective:
To identify barriers and facilitators to transitioning to primary human papillomavirus (HPV) testing from current cervical cancer screening practices among community OB/GYN physicians.
Methods:
We conducted an exploratory qualitative study with in-depth interviews of 10 community-based OB/GYNs. Interviews were semistructured, utilizing an interview guide informed by the Consolidated Framework for Implementation Research, designed to explore current screening practices, perceptions of cytology versus primary HPV testing, recommended screening intervals, patient and physician acceptance of HPV-based testing, and anticipated changes in practice. Interviews were coded for recurring themes and organized into provider-, patient-, and system-level domains.
Results:
Identified barriers included interprovider variability in cervical cancer screening practices, fear of missing a cancer, concerns about loss of follow-up, patient preferences for more frequent screening, and talking about HPV with patients as a stressful/difficult process. Identified facilitators included awareness of possible upcoming changes in cervical cancer screening recommendations and previous adjustments in approach to cervical cancer screening.
Conclusions:
Transitioning to this evidence-based cervical cancer screening modality will require targeted, multilevel strategies to address physician concerns and to promote the acceptability and adoption of primary HPV testing.
Related Concept Videos
Primary Healthcare Services
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
Preventive Healthcare Services
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Prevention
Some...
Cancer Prevention
PPE Use in Healthcare Settings I: Donning

